1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 29188408 | Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC. | 2018 Feb | 1 |